AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24284115
Drug: 5% ALA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% ALA gel applied topically for 1h incubation followed by LED light irradiation at 633 nm, 96-120 J/cm² for 3-4 sessions
Trial: 19074355
Drug: Massage therapy
RxNorm normalized name: CAMPHOR (SYNTHETIC) 30 g in 1 mL / MENTHOL 40 g in 1 mL TOPICAL OIL [CBDMEDIC MASSAGE THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage therapy (4 weekly sessions)
Trial: 19074355
Drug: Quiet-time control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quiet-time control (4 weekly sessions)
Trial: 14743852
Drug: Intermittent infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent infusion of intravenous inotropes
Trial: 11319593
Drug: Heparin (Hep)
RxNorm normalized name: heparin sodium, porcine Injectable Solution [Hep-Pak]
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heparin (Hep)
Trial: 11319593
Drug: Heparin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin + Prostaglandin E1 (Hep + PGE1)
Trial: 9345174
Drug: Control (alphabetical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (alphabetical list of drugs)
Trial: 9345174
Drug: Limited support
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Limited support (list of preferred drugs)
Trial: 8084119
Drug: Erinit and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erinit and allopurinol in conventional therapeutical doses
Trial: 27306372
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg roflumilast
Trial: 27306372
Drug: 0.375 mg
RxNorm normalized name: vitamin A 0.375 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.375 mg roflumilast
Trial: 27306372
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg roflumilast
Trial: 27306372
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses of 0.375 mg roflumilast
Trial: 26474518
Drug: Bevacizumab plus
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab plus erlotinib (150 mg once daily)
Trial: 24942210
Drug: Bevacizumab (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab (7.5 mg/kg every 3 weeks)
Trial: 21609207
Drug: Vildagliptin 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin 400 mg
Trial: 19332727
Drug: Adjuvant doxorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant doxorubicin (75 mg/m(2)) followed by CMF
Trial: 19332727
Drug: Adjuvant paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Adjuvant paclitaxel (200 mg/m(2)) plus doxorubicin (60 mg/m(2)), followed by CMF
Trial: 19332727
Drug: Paclitaxel (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (200 mg/m(2)) plus doxorubicin (60 mg/m(2)) followed by CMF followed by surgery
Trial: 15288707
Drug: Dexamethasone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (1 mg orally at 2300 h)
Trial: 9801900
Drug: BCG vaccine
RxNorm normalized name: BCG Vaccine
DrugBank: BCG vaccine (DB12768)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG vaccine (batch 1)
Trial: 9801900
Drug: BCG vaccine
RxNorm normalized name: BCG Vaccine
DrugBank: BCG vaccine (DB12768)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG vaccine (batch 2)
Trial: 336078
Drug: Bellergal (combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bellergal (combination of belladonna alkaloids, ergotamine tartrate, and phenobarbitone), administered three times daily
Trial: 24655978
Drug: EVL plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EVL plus atorvastatin 20 mg
Trial: 22979932
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment for dry eye (3 weeks duration)
Trial: 22979932
Drug: Artificial tear
RxNorm normalized name: Artificial Tears
DrugBank: Polyethylene glycol 400 (DB11077)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial tear therapy (control group, 3 weeks duration)
Trial: 22979932
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (1 week after treatment)
Trial: 19203163
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual for juvenile sexual offenders (TAU-JSO)
Trial: 17301733
Drug: Grapefruit juice
RxNorm normalized name: grapefruit juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grapefruit juice (300 ml) with 120 mg fexofenadine
Trial: 17301733
Drug: Aqueous solution
RxNorm normalized name: Zephiran Chloride 1:750 Antiseptic Aqueous Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous solution of naringin (1,200 microM) with 120 mg fexofenadine
Trial: 17301733
Drug: Grapefruit juice
RxNorm normalized name: grapefruit juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grapefruit juice with 120 mg fexofenadine
Trial: 17301733
Drug: Particulate fraction
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Particulate fraction of juice with 120 mg fexofenadine
Trial: 7924123
Drug: Amoxicillin administered
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin administered as a bolus (375 mg in 120 ml water)
Trial: 7924123
Drug: Amoxicillin administered
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin administered as a 4-hour infusion (375 mg in 120 ml water)
Trial: 7924123
Drug: Amoxicillin administered
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin administered as a bolus in the ileum
Trial: 7924123
Drug: Amoxicillin administered
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin administered as a 4-hour infusion in the ileum
Trial: 7924123
Drug: Amoxicillin infused
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin infused in colonic regions
Trial: 7924123
Drug: Oral dose
RxNorm normalized name: Exactamed Oral Dose Syringe 35cc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dose of amoxicillin solution
Trial: 31942838
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg grape seed polyphenol extract (GSPE)
Trial: 22882753
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg sumatriptan tablet with 50 mL of water
Trial: 22882753
Drug: 50 mL
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mL of water alone (control)
Trial: 20335070
Drug: Clopidogrel (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (300 mg for the first day, then 75 mg daily) plus aspirin (75-160 mg daily)
Trial: 20335070
Drug: Aspirin alone
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin alone (75-160 mg daily)
Trial: 19290473
Drug: Lornoxicam 8
RxNorm normalized name: lornoxicam 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lornoxicam 8 mg i.v. at the end of the operation, followed by 8 mg 12 h after the operation
Trial: 19290473
Drug: Tramadol 1
RxNorm normalized name: tramadol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 1 mg/kg at the end of the operation and every 6 h up to 24 h postoperatively
Trial: 12610744
Drug: Lamotrigine (LTG)
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine (LTG) 2.5 microg/ml
Trial: 12610744
Drug: Lamotrigine (LTG)
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine (LTG) 10 microg/ml
Trial: 12610744
Drug: Reference compound
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference compound antipyrine (100 microg/ml)
Trial: 10582898
Drug: Oral trovafloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral trovafloxacin (200 mg)
Trial: 10582898
Drug: Intravenous alatrofloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous alatrofloxacin
Trial: 8692619
Drug: Dexamethasone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (0.5 mg/kg per day for 12 days, tapered progressively)
Trial: 1879386
Drug: Seventeen meals
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seventeen meals daily
Trial: 1879386
Drug: Three meals
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three meals daily
Trial: 6603716
Drug: Netilmicin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Netilmicin (5 mg/kg body weight, intramuscular injection)
Trial: 6603716
Drug: Netilmicin combined
RxNorm normalized name: netilmicin
DrugBank: Netilmicin (DB00955)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Netilmicin combined with beta-Lactam antibiotics
Trial: 30905227
Drug: Long-term antenatal
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term antenatal indomethacin treatment (LIT)
Trial: 29767754
Drug: OS‐IUI cycles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OS‐IUI cycles (all treatments)
Trial: 17316487
Drug: E‐Zagreb, L‐Zagreb,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E‐Zagreb, L‐Zagreb, and Wistar RA 27/3 (Tresivac)
Trial: 12611835
Drug: Lorazepam 6
RxNorm normalized name: Lorazepam
DrugBank: Lorazepam (DB00186)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lorazepam 6 mg/day
Trial: 9343646
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg intra-articular morphine
Trial: 23281420
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg intra-articular morphine
Trial: 9343646
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg intravenous morphine
Trial: 17468821
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg bupivacaine
Trial: 8338088
Drug: Oral sodium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sodium phosphate (Fleet Phospho‐Soda)
Trial: 8338088
Drug: Standard polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard polyethylene glycol‐based lavage solution (GoLYTELY)
Trial: 3505526
Drug: Verapamil 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 5 mg/2 ml
Trial: 3505526
Drug: Verapamil 10
RxNorm normalized name: verapamil 100 mg/24 hours oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 10 mg/4 ml
Trial: 1838690
Drug: Atrial natriuretic
RxNorm normalized name: Atrial natriuretic factor
DrugBank: Atrial natriuretic peptide (DB15591)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrial natriuretic factor (ANF) infusion (0.04 micrograms/kg/min)
Trial: 8038755
Drug: Vehicle (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle (50 mL of isotonic saline)
Trial: 6217950
Drug: 1.0 g
RxNorm normalized name: IODINE 11.0 g in 1 L TOPICAL SOLUTION [T.D.]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 g mezlocillin
Trial: 6217950
Drug: 2.0 g
RxNorm normalized name: Fifty50 2.0 Glucose Meter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 g ampicillin plus 1.0 g probenecid orally
Trial: 28784657
Drug: Cholecalciferol (2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol (2000 IU daily)
Trial: 28784657
Drug: Calcitriol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitriol (0.5 μg daily)
Trial: 26393990
Drug: Musical auditory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Musical auditory stimulation in the control group (12 women not taking oral contraceptives)
Trial: 26393990
Drug: Musical auditory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Musical auditory stimulation in the oral contraceptive group (10 women taking oral contraceptives)
Trial: 24038913
Drug: 3-6 years
RxNorm normalized name: hypromellose
DrugBank: Hypromellose (DB11075)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-6 years treated with irradiation and chemotherapy
Trial: 24215215
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of azithromycin (AZM)
Trial: 12404692
Drug: 0.66 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.66 g/kg alcohol
Trial: 12404692
Drug: caffeine (110-120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: caffeine (110-120 mg)
Trial: 8669216
Drug: Morphine PCA
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine PCA (2 mg/ml or 3 mg/ml)
Trial: 2178869
Drug: Acetyl-l-carnitine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-l-carnitine (1 g twice daily)
Trial: 2178869
Drug: Acetyl-l-carnitine
RxNorm normalized name: acetyl-L-carnitine
DrugBank: Acetylcarnitine (DB08842)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-l-carnitine
Trial: 30839477
Drug: Healthy Hip
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healthy Hip Diaper (prophylactic treatment)
Trial: 28802619
Drug: Sugammadex 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 2.0 mg/kg at T2 after rocuronium
Trial: 28802619
Drug: Sugammadex 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 2.0 mg/kg at T2 after vecuronium
Trial: 28802619
Drug: Sugammadex 4.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 4.0 mg/kg at 1–2 PTC after rocuronium
Trial: 28802619
Drug: Sugammadex 4.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 4.0 mg/kg at 1–2 PTC after vecuronium
Trial: 28802619
Drug: Sugammadex 16.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 16.0 mg/kg at 3 min after rocuronium 1.2 mg/kg
Trial: 23018466
Drug: Subcutaneous bortezomib
RxNorm normalized name: Bortezomib
DrugBank: Bortezomib (DB00188)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Subcutaneous bortezomib 1.3 mg/m²
Trial: 23018466
Drug: Intravenous bortezomib
RxNorm normalized name: Bortezomib
DrugBank: Bortezomib (DB00188)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravenous bortezomib 1.3 mg/m²
Trial: 23018466
Drug: Subcutaneous bortezomib
RxNorm normalized name: Bortezomib
DrugBank: Bortezomib (DB00188)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Subcutaneous bortezomib 1.3 mg/m² (CAN-1004)
Trial: 23018466
Drug: Intravenous bortezomib
RxNorm normalized name: Bortezomib
DrugBank: Bortezomib (DB00188)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravenous bortezomib 1.3 mg/m² (CAN-1004)
Trial: 3285278
Drug: Levamisole (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole (2.5 mg/kg/day on days 1 and 2 of each week for 18 months)
Trial: 31207648
Drug: Daily echocardiography
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily echocardiography
Trial: 28669360
Drug: Prolonged Exposure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged Exposure (PE) therapy via telehealth
Trial: 28669360
Drug: Prolonged Exposure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged Exposure (PE) therapy in person
Trial: 22481619
Drug: Intra-vaginal fenticonazole
RxNorm normalized name: fenticonazole
DrugBank: Fenticonazole (DB13434)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-vaginal fenticonazole 600 mg
Trial: 20160158
Drug: Lenalidomide 25
RxNorm normalized name: lenalidomide 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenalidomide 25 mg once daily for 4 days
Trial: 12653794
Drug: Ciclesonide (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciclesonide (800 micro g twice daily)
Trial: 1816122
Drug: Single 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 1 g dose of cefotaxime
Trial: 1816122
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses of cefotaxime
Trial: 1816122
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg metronidazole i.v. every 12 h for 72 h
Trial: 29236165
Drug: Dose 1
RxNorm normalized name: Aldose 1-epimerase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose 1 Curry (D1C)
Trial: 29236165
Drug: Dose 2
RxNorm normalized name: Fluzone High-Dose 2011-2012
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose 2 Curry (D2C)
Trial: 29236165
Drug: Dose 0
RxNorm normalized name: Femhrt Low Dose 0.5/2.5 Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose 0 Control (D0C)
Trial: 17385190
Drug: Supportive-expressive group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive-expressive group therapy (SEGT) plus three classes of relaxation therapy
Trial: 17385190
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group receiving three classes of relaxation therapy
Trial: 16350553
Drug: 140 ml@4ml/s
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 140 ml@4ml/s
Trial: 16350553
Drug: 140 ml
RxNorm normalized name: syringe, disposable, 140 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 140 ml = 60 ml@5ml/s + 80 ml@3ml/s
Trial: 16350553
Drug: 100 ml@4ml/s
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 ml@4ml/s
Trial: 11408506
Drug: VA chemotherapy
RxNorm normalized name: VP/VA COPOLYMER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VA chemotherapy
Trial: 9723149
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of referral strategies (fixed appointment, involvement of the family, presence of the aftercare person, motivational counselling)
Trial: 7994812
Drug: Trapidil 100
RxNorm normalized name: trapidil
DrugBank: Trapidil (DB09283)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trapidil 100 mg TID
Trial: 7994812
Drug: Aspirin 100
RxNorm normalized name: aspirin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 100 mg TID
Trial: 31022555
Drug: Literacy-adapted group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Literacy-adapted group cognitive-behavioral therapy (CBT)
Trial: 20383545
Drug: 10% casein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% casein phosphopeptide‐amorphous calcium phosphate (CPP‐ACP) applied once daily (Tooth Mousse, GC Europe)
Trial: 19468787
Drug: Pentoxyphylline (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxyphylline (800 mg daily) and vitamin E (800 UI daily)
Trial: 15841813
Drug: Resting whole
RxNorm normalized name: Betula lenta whole
DrugBank: Betula lenta whole (DB14164)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resting whole salivary secretion rate < or =0.1 mL/min
Trial: 15841813
Drug: Stimulated whole
RxNorm normalized name: Betula lenta whole
DrugBank: Betula lenta whole (DB14164)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulated whole salivary flow rates <0.7 mL/min
Trial: 8956556
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment of variceal bleeding
Trial: 2581467
Drug: Cimetidine 100
RxNorm normalized name: cimetidine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 100 mg orally once a day for 4 weeks
Trial: 30958069
Drug: 12 µg
RxNorm normalized name: penicillin G 12 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 µg of formoterol (FOR)
Trial: 30958069
Drug: 100 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 µg of salmeterol (SAL)
Trial: 30139419
Drug: Oral caffeine
RxNorm normalized name: caffeine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral caffeine supplementation (400 mg per dancer, 6.3 mg/kg, range: 4.9 to 8.6 mg/kg)
Trial: 19056575
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (1 mg . kg(‐1) . d(‐1)) from 4 to 9 months
Trial: 19056575
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (1 mg . kg(‐1) . d(‐1)) from 6 to 9 months
Trial: 17634458
Drug: Certolizumab pegol
RxNorm normalized name: Certolizumab Pegol
DrugBank: Certolizumab pegol (DB08904)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Certolizumab pegol 400 mg subcutaneously at weeks 0, 2, and 4, then every 4 weeks
Trial: 12847475
Drug: Disodium cromoglycate
RxNorm normalized name: Disodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disodium cromoglycate (5 mg qid)
Trial: 10597739
Drug: Accelerated weekly
RxNorm normalized name: Serum prothrombin conversion accelerator
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated weekly schedule (AWS) of cisplatin (100 mg/m2 every week for two triplets of three cycles separated by a 5-week interval)
Trial: 10597739
Drug: Conventional 3-weekly
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Conventional 3-weekly schedule (CTWS) of cisplatin (100 mg/m2 every 3 weeks for six cycles)
Trial: 7036726
Drug: Diltiazem 120
RxNorm normalized name: diltiazem 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 120 mg per day